The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life(QoL) outcomes including neuropathy associated scale (FACT-T) from a phase II, multicenter, randomized trial of eribulin plus gemcitabine(EG) versus paclitaxel plus gemcitabine(PG) as first-line chemotherapy for human epidermal growth factor receptor 2 (HER2)- negative metastatic breast cancer(MBC): Korean Cancer Study Group trial (KCSG BR13-11).
 
Ji-Yeon Kim
No Relationships to Disclose
 
Seri Park
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - Hanmi; Novartis; Pfizer
Research Funding - AstraZeneca
 
Sung-Bae Kim
Research Funding - Dongkook; Kyowa Hakko Kirin; Novartis; Sanofi
 
Joohyuk Sohn
No Relationships to Disclose
 
Keun-Seok Lee
No Relationships to Disclose
 
Ki Hyeong Lee
No Relationships to Disclose
 
Jee Hyun Kim
No Relationships to Disclose
 
Young-Hyuck Im
No Relationships to Disclose
 
Tae Yong Kim
No Relationships to Disclose
 
Kyung-Hun Lee
No Relationships to Disclose
 
Jin-Hee Ahn
No Relationships to Disclose
 
Gun Min Kim
No Relationships to Disclose
 
In Hae Park
No Relationships to Disclose
 
Yee Soo Chae
No Relationships to Disclose
 
Soo Jung Lee
No Relationships to Disclose
 
Hye Sook Han
No Relationships to Disclose
 
Se Hyun Kim
No Relationships to Disclose
 
Kyung Hae Jung
No Relationships to Disclose
 
Yeon Hee Park
No Relationships to Disclose